• Je něco špatně v tomto záznamu ?

From big data to better patient outcomes

T. Hulsen, D. Friedecký, H. Renz, E. Melis, P. Vermeersch, P. Fernandez-Calle

. 2023 ; 61 (4) : 580-586. [pub] 20221222

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003743

Among medical specialties, laboratory medicine is the largest producer of structured data and must play a crucial role for the efficient and safe implementation of big data and artificial intelligence in healthcare. The area of personalized therapies and precision medicine has now arrived, with huge data sets not only used for experimental and research approaches, but also in the "real world". Analysis of real world data requires development of legal, procedural and technical infrastructure. The integration of all clinical data sets for any given patient is important and necessary in order to develop a patient-centered treatment approach. Data-driven research comes with its own challenges and solutions. The Findability, Accessibility, Interoperability, and Reusability (FAIR) Guiding Principles provide guidelines to make data findable, accessible, interoperable and reusable to the research community. Federated learning, standards and ontologies are useful to improve robustness of artificial intelligence algorithms working on big data and to increase trust in these algorithms. When dealing with big data, the univariate statistical approach changes to multivariate statistical methods significantly shifting the potential of big data. Combining multiple omics gives previously unsuspected information and provides understanding of scientific questions, an approach which is also called the systems biology approach. Big data and artificial intelligence also offer opportunities for laboratories and the In Vitro Diagnostic industry to optimize the productivity of the laboratory, the quality of laboratory results and ultimately patient outcomes, through tools such as predictive maintenance and "moving average" based on the aggregate of patient results.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003743
003      
CZ-PrNML
005      
20230425140845.0
007      
ta
008      
230418s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/cclm-2022-1096 $2 doi
035    __
$a (PubMed)36539928
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Hulsen, Tim $u Department of Hospital Services & Informatics, Philips Research, Eindhoven, The Netherlands $1 https://orcid.org/0000000202088443
245    10
$a From big data to better patient outcomes / $c T. Hulsen, D. Friedecký, H. Renz, E. Melis, P. Vermeersch, P. Fernandez-Calle
520    9_
$a Among medical specialties, laboratory medicine is the largest producer of structured data and must play a crucial role for the efficient and safe implementation of big data and artificial intelligence in healthcare. The area of personalized therapies and precision medicine has now arrived, with huge data sets not only used for experimental and research approaches, but also in the "real world". Analysis of real world data requires development of legal, procedural and technical infrastructure. The integration of all clinical data sets for any given patient is important and necessary in order to develop a patient-centered treatment approach. Data-driven research comes with its own challenges and solutions. The Findability, Accessibility, Interoperability, and Reusability (FAIR) Guiding Principles provide guidelines to make data findable, accessible, interoperable and reusable to the research community. Federated learning, standards and ontologies are useful to improve robustness of artificial intelligence algorithms working on big data and to increase trust in these algorithms. When dealing with big data, the univariate statistical approach changes to multivariate statistical methods significantly shifting the potential of big data. Combining multiple omics gives previously unsuspected information and provides understanding of scientific questions, an approach which is also called the systems biology approach. Big data and artificial intelligence also offer opportunities for laboratories and the In Vitro Diagnostic industry to optimize the productivity of the laboratory, the quality of laboratory results and ultimately patient outcomes, through tools such as predictive maintenance and "moving average" based on the aggregate of patient results.
650    _2
$a lidé $7 D006801
650    12
$a big data $7 D000077558
650    12
$a umělá inteligence $7 D001185
650    _2
$a algoritmy $7 D000465
650    _2
$a poskytování zdravotní péče $7 D003695
650    _2
$a individualizovaná medicína $x metody $7 D057285
655    _2
$a časopisecké články $7 D016428
700    1_
$a Friedecký, David $u Department of Clinical Biochemistry, Laboratory for Inherited Metabolic Disorders, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic
700    1_
$a Renz, Harald $u Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL), and the Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, Marburg, Germany $u Department of Clinical Immunology and Allergy, Laboratory of Immunopathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
700    1_
$a Melis, Els $u Ortho Clinical Diagnostics, Zaventem, Belgium
700    1_
$a Vermeersch, Pieter $u Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium $u Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium $u European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Milan, Italy $1 https://orcid.org/000000017076061X
700    1_
$a Fernandez-Calle, Pilar $u European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Milan, Italy $u Department of Laboratory Medicine, Hospital Universitario La Paz, Madrid, Spain
773    0_
$w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 61, č. 4 (2023), s. 580-586
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36539928 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140841 $b ABA008
999    __
$a ok $b bmc $g 1924427 $s 1189952
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 61 $c 4 $d 580-586 $e 20221222 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace